Supplementary Data1 from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco
Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, Daniele Ognissanti et autres